Agenus | AGEN - Dochód Netto





Dochód Netto Zmiana Data
AbbVie USD 3.61B 2.92B 2026-06
Agenus USD 39.17M 49.8M 2026-03
Amgen USD 2.38B 556M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Celldex Therapeutics USD -73.5M 5.18M 2026-06
CSL USD 401M 96.5M 2025-12
Eli Lilly USD 7.1B 301M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Glaxosmithkline GBP 1.74B 890.94M 2026-03
Incyte USD 585.6M 282.27M 2026-06
J&J USD 5.53B 299M 2026-06
Jiangsu Hengrui CNY 2.18B 99.1M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
MacroGenics USD -36.77M 22.62M 2026-03
Merck EUR 490M 169M 2026-06
Merck USD -1.34B 2.9B 2026-06
Northwest Biotherapeutics USD -3.4M 23.78M 2026-03
Novartis USD 3.26B 108M 2026-06
Novavax USD 17.53M 219.91M 2025-12
Pfizer USD -248M 2.94B 2026-06
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Veracyte USD 25.49M 3.22M 2026-06